Measurement of Crosslinked Fibrin Degradation Products in Thrombolytic Therapy of Patients With Thromboembolic Diseases.

Blood & Vessel
doi 10.2491/jjsth1970.19.77
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society on Thrombosis and Hemostasis

Related search

Measurement of Crosslinked Fibrin Derivatives by a New Reagent in Patients With Thromboembolic Diseases.

Blood & Vessel
1989English

Fibrin Degradation Products.

BMJ
1970English

Fibrin Degradation Products.

BMJ
1969English

Assessment of Fibrin Degradation Products During Fibrinolytic Therapy for Acute Myocardial Infarction

Circulation
Cardiovascular MedicinePhysiologyCardiology
1986English

Serial Estimation of Urinary Fibrin/Fibrinogen Degradation Products in Kidney Transplantation

BMJ
1973English

Analysis of Incidence of Thromboembolic Complications in Patients With Chronic Lymphoproliferative Diseases

Medicinski podmladak
2015English

Modification by Drugs of Urinary Fibrin Fibrinogen Degradation Products in Glomerulonephritis

BMJ
1972English

Identification and Distribution of Fibrinogen, Fibrin, and Fibrin(ogen) Degradation Products in Atherosclerosis. Use of Monoclonal Antibodies

Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
1989English

Thrombolytic Therapy and Mortality in Patients With Acute Pulmonary Embolism

Archives of Internal Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy